Scaling Manufacturing, Not Facilities: Demonstrating the potential of a microfluidic-powered Cell Factory to make CAR-T better, faster, cheaper!

• Demonstrate a novel all-in-one CAR-T process development and manufacturing approach based on microfluidic technology
• Deliver scientific proof points to enable orderof-magnitude improvements in manufacturing cost, patient access and CapEx investment related to cell therapies

Speakers:

Thomas Denefle

PhD, MBA, Director of Product Management & Early Access

Astraveus

Paul Cochard-Marchewka

PhD, BD Specialist

Astraveus

Thomas Denefle

Head of Product Management

Astraveus